AI주식인사이트AI Stock Insight
C

젬백스

082270KOSDAQ특수 목적용 기계 제조업

45.3 / 100

Reference Date: 2026-07-24

Financial Score9.5 / 40
News Sentiment18.8 / 25
Momentum3.0 / 20
Disclosure14.0 / 15
AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Plunged 15.7% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

jemBucks operates two main business segments: an environmental pollution control division producing chemical filters and air purification systems for semiconductor and display manufacturing, and a biotech division conducting clinical trials for GV1001, a telomerase-derived peptide drug candidate for Alzheimer's disease. The environmental division accounts for 99.2% of 2024 sales with its flagship product, the Chemical Air Filter, while the biotech division focuses on developing next-generation peptide drugs based on GV1001's anti-inflammatory and neuroprotective properties.

Number of Employees

217people

Average Salary

46.9M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 18.674.0Point
PBR
—Industry Average 1.023.5Point
ROE
-26.29Industry Average 1.160.0Point

Well below industry avg

Debt Ratio
63.27Industry Average 7.710.0Point

8.2x industry avg (risky)

Trend 2023~20252.0 / 10 points
Revenue Growth Rate
2.0 / 3

Avg ▲8.4% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼138.7% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -58.7% (declining, 3yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 75

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 10,230Won52-week high 59,30052-week low 9,740
1-month return0.0Point

1m -15.73% (strong drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

3 totalPositive 2Neutral 1Negative 0
  • Neutral주식등의대량보유상황보고서(일반)2026-07-22
  • Positive[기재정정]최대주주변경을수반하는주식담보제공계약체결2026-07-20
  • Positive[기재정정]최대주주변경을수반하는주식담보제공계약체결2026-07-15